Henrique Bracarense Fagioli

Mr. Henrique Bracarense Fagioli

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2025 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
MAMônica Viegas Andrade
Mônica Viegas Andrade
KNKenya Valeria Micaela de Souza Noronha
Kenya Valeria Micaela de Souza Noronha
ASAline de Souza
Aline de Souza
NJNayara Abreu Julião
Nayara Abreu Julião
AMAndré Soares Motta-Santos
André Soares Motta-Santos
ARAntônio Luiz Pinho Ribeiro
Antônio Luiz Pinho Ribeiro
Chagas disease remains a public health issue with substantial financial impact on the healthcare system of Latin American countries. Despite its great economic burden, research quantifying the direct and indirect costs are limited, particularly within Brazil. This study estimates the economic burden of chronic Chagas disease in Brazil, as part of the broader project, ‘The Burden of Chagas Disease in the Contemporary World: The RAISE Study’. A Markov model was used to estimate the economic burden of chronic Chagas disease from a societal perspective considering six mutually exclusive health states: four clinical forms (indeterminate, cardiac, digestive, mixed) and two absorptive states (death and cure). This model was analyzed through microsimulation with a one-year cycle length, considering a hypothetical cohort of 10,000 patients, each repeated 1000 times to report the average. Data on costs were gathered, converted to 2024 purchasing power parity US dollars, and considered direct medical costs and productivity losses due to absenteeism. The annual economic burden of chronic Chagas disease in Brazil was estimated at $11.44 billion, constituting 0.23% of the gross domestic product, with a lifetime cost per patient of $45,034. Lifetime direct medical costs represent around 72% of the total lifetime economic burden, while indirect costs, 28%. Annual direct medical costs represent around 11% of the Ministry of Health budget. The significant economic burden highlights the necessity for effective public health policies and resource allocation in Brazil's healthcare system. Given the universal health coverage model, understanding these costs can guide improvements and interventions aimed at reducing Chagas disease’s impact. Funding was provided by Novartis Pharma AG as part of a research collaboration with the 10.13039/501100015708 World Heart Federation , project number CLCZ696D2010R.

15 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
TCThaís Cristina Marquezine Caldeira
Thaís Cristina Marquezine Caldeira
LNLAURA DE CASTRO NASSIF
LAURA DE CASTRO NASSIF
TSTaciana Maia de Sousa
Taciana Maia de Sousa
EMEmanuella Gomes Maia
Emanuella Gomes Maia
HFHenrique Bracarense Fagioli
Henrique Bracarense Fagioli
RCRafael Claro
Rafael Claro
Background/Objectives: Food prices are a crucial factor in food choices, especially for more vulnerable populations. To estimate the association between diet cost and quality, as measured by the EAT-Lancet score, across demographic groups in Brazil. Methods: Data from the 2017/18 Household Budget Survey were used to calculate the EAT-Lancet score, comprising 14 components. Scores ranged from 0 (low adherence) to 42 (high adherence), with emphasized components (e.g., vegetables, fruits, legumes) and limited components (e.g., red meat, sugar, eggs). Results were stratified by per capita income, geographic region, and area of residence and compared using linear regression adjusted for high and low costs. In addition, the association between the EAT-Lancet score (and its emphasized and limited components) and diet cost (continuous) was analyzed for the total population and for income tertiles. Results: The mean EAT-Lancet score was 18.65 points (range: 7 to 25) and the mean diet cost was BRL$0.65/100 kcal. Total scores showed no significant difference between low- and high-cost diets. However, limited intake was more pronounced in low-cost diets, while high-cost diets featured emphasized foods such as fruits, vegetables, and seafood. High-cost diets also included sugars and red meat, while unsaturated fats scored higher in low-cost diets. Each one-point increase in the EAT-Lancet score was associated with a BRL$0.38 reduction in cost, driven by lower costs in the Limited component, especially among the lowest-income strata (reductions of BRL$1.58 and BRL$1.55 in the lowest income and middle income tertiles, respectively). However, higher scores for emphasized foods increased costs (BRL$0.89) in the lowest tertile. Conclusions: Higher EAT-Lancet scores were associated with reduced diet costs, likely influenced by the lower Limited component costs in low-income groups. Emphasized foods, however, tended to increase costs, particularly among the lowest-income group. These findings suggest that the role of diet composition plays a significant role in cost differences and underscore the challenges that low-income groups face in accessing affordable, healthy diets.

6 November 2024 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
MAMônica Viegas Andrade
Mônica Viegas Andrade
KNKenya Noronha
Kenya Noronha
GGGilvan Ramalho Guedes
Gilvan Ramalho Guedes
BDBernardo Campolina Diniz
Bernardo Campolina Diniz
VSValéria Andrade Silva
Valéria Andrade Silva
MCMarcia Castro
Marcia Castro
Purpose This paper aims to conduct a systematic review (SR) to assess Health-Related Quality of Life (HRQoL) of malaria-exposed populations for different regions where malaria is endemic, considering any health measurements. Methods An electronic search of the Medline, Lilacs, and Embase databases was conducted until February 2nd, 2024, to identify and select studies that evaluated HRQoL. No restrictions on place or language were made. Results Thirty-seven studies were included, among them 21 focused on African countries. The most investigated HRQoL outcome associated with malaria was Disability-Adjusted Life Years (DALYs). These studies primarily aim to analyze the epidemiological burden of the disease or to conduct economic assessments. Only four studies conducted field research using specific instruments to assess the HRQoL of individuals experiencing malaria episodes. Three of them estimated EQ-5D utility index and found scores varying from 0.349 for severe malaria (Indonesia) to 0.74 (Nigeria). The health domains that are most affected by malaria are pain and discomfort and usual activities (EQ-5D instrument) and physical domains (WHOQOL-BREF). These results reflect the main malaria symptoms which are fever, headache, and generalized pain. Conclusion This SR highlights a significant gap in understanding the quality of life among individuals experiencing malaria. Despite being an acute illness, recurrent episodes of malaria can lead to considerable loss in quality of life. Moreover, there are significant equity implications, as malaria remains endemic in socioeconomically disadvantaged populations.

1 January 2023 in Cadernos do Desenvolvimento
Verified
Journal Article
Open access
PDF file
HFHenrique Bracarense Fagioli
Henrique Bracarense Fagioli
ACAnderson Tadeu Marques Cavalcante
Anderson Tadeu Marques Cavalcante
MAMarco Aurélio Crocco Afonso
Marco Aurélio Crocco Afonso
Bancos Nacionais de Desenvolvimento (BNDs) consistem em importantes agentes da política pública, tendo seu papel como fonte de financiamento do desenvolvimento reapreciado no pós-Grande Recessão de 2008. No caso do Brasil, o BNDES, consistindo em um dos maiores BNDs do mundo, teve seu protagonismo na economia brasileira desafiado em decorrência do continuado debate acerca da presença do Estado na atividade econômica. O presente artigo visa a avaliar a atuação dos BNDs no financiamento do desenvolvimento sustentável, especificamente focando no caso brasileiro. O BNDES, um dos principais agentes nacionais na promoção do financiamento do desenvolvimento sustentável, atuou contraciclicamente de maneira fundamental na grave crise iniciada em 2014, materializando sua Política de Responsabilidade Ambiental. O Fundo Clima, com investimentos concentrados em infraestrutura e energia elétrica, revela a importância do banco na consecução dos Objetivos de Desenvolvimento Sustentável no país.

20 December 2025 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
MAMônica Viegas Andrade
Mônica Viegas Andrade
KNKenya Valeria Micaela de Souza Noronha
Kenya Valeria Micaela de Souza Noronha
ASAline de Souza
Aline de Souza
NJNayara Abreu Julião
Nayara Abreu Julião
AMAndré Soares Motta-Santos
André Soares Motta-Santos
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
Chagas disease (ChD) remains a public health concern in Latin America. Despite a decline in overall prevalence, the chronic symptomatic forms still impose a substantial epidemiological and economic burden. This study undertakes a comprehensive, population-based cost analysis of chronic Chagas disease (CCD) from a societal perspective in seven endemic Latin American countries for 2010 and 2023. A Markov model with one-year cycles and six states was employed. Direct medical and indirect costs, converted to 2024 purchasing power parity US dollars, were estimated using prevalence data from the Global Burden of Disease Study 2023. Based on a previous Brazilian Markov model, parameters were adjusted using healthcare coverage and per capita health expenditure ratios for each country, further validated by national experts. In 2010, Brazil (US$252 billion) and Argentina (US$164 billion) had the highest lifetime burdens. As a percentage of annual Gross Domestic Product, Bolivia (0·9%) and Argentina (0·8%) were most affected. CCD accounted for 6% of total health expenditures in both countries. Between 2010 and 2023, most countries experienced a decline in economic burden due to decreased CCD prevalence, despite an increased proportion of patients with cardiac conditions, reflecting population aging and disease progression. CCD imposes substantial economic burden across Latin American countries. Epidemiological shift to older populations with severe cardiac forms signals increased healthcare demands. Findings inform policymakers for resource allocation and tailored interventions. Funding was provided by Novartis Pharma AG as part of a research collaboration with the 10.13039/501100015708 World Heart Federation (project number CLCZ696D2010R).

14 May 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
MAMonica Viegas Andrade
Monica Viegas Andrade
KNKenya Valeria Micaela de Souza Noronha
Kenya Valeria Micaela de Souza Noronha
GGGilvan R. Guedes
Gilvan R. Guedes
LCLucas Resende de Carvalho
Lucas Resende de Carvalho
HFHenrique Bracarense Fagioli
Henrique Bracarense Fagioli
MCMarcia Castro
Marcia Castro
Malaria remains a global health challenge, imposing a substantial economic burden on health systems and society. Comprehensive assessments of this burden have been limited. This study aimed to provide a detailed estimate of the economic burden of malaria in the Brazilian Amazon. Public health expenditures were derived from a previous study. Direct, and indirect household costs and Health-Related Quality-of-Life (HRQoL) losses were estimated using a household survey conducted in nine municipalities in five states of the Brazilian Amazon. Expenditure data were collected from 1,131 individuals who experienced a malaria episode between January 2019 and May 2022. All costs were monetized and converted to 2024 purchasing power parity US dollars (PPP-USD). The total economic burden of malaria in the Amazon in 2019 was approximately US$181.9 million PPP-USD. The Unified Health System (SUS) bore the largest share (72.4%), which was allocated primarily to control and prevention activities. The states of Amazonas, Pará, and Roraima bore the highest total burden. Household burden was predominantly driven by indirect and mortality costs, and HRQoL losses. Major limitations of the study included convenience sampling and potential recall bias regarding expenditures; the latter was mitigated by surveying items and quantities rather than monetary values. This study offers a comprehensive and unparalleled assessment of the economic burden of malaria, providing a foundation for developing effective malaria control policies at the national and local levels in Brazil. Our findings underscore the critical role of the SUS in shielding families from direct medical costs, while revealing the substantial indirect costs, health-related quality-of-life losses, and mortality-related losses borne by households. These insights are essential for informing resource allocation and strengthening malaria control and elimination strategies in the Brazilian Amazon. The study provides a conceptual framework for estimating the economic cost of malaria that can be adapted to other malaria-endemic countries.